Papillary predominant histological subtype predicts poor survival in lung adenocarcinoma

Simple item page
dc.contributor.authorDemet YALDIZ
dc.contributor.authorArkın ACAR
dc.contributor.authorŞeyda ÖRS KAYA
dc.contributor.authorZekiye AYDOĞDU
dc.contributor.authorSoner GÜRSOY
dc.contributor.authorSadık YALDIZ
dc.date.accessioned2024-07-24T09:09:54Z
dc.date.available2024-07-24T09:09:54Z
dc.date.issued2019
dc.description.abstractBackground: This study aims to investigate whether papillarypredominant histological subtype can predict poor survival inlung adenocarcinoma.Methods: Between January 2005 and December 2016,a total of 80 patients with papillary predominant subtype lungadenocarcinoma (70 males, 10 females; mean age 60.7 years;range, 42 to 79 years) operated in our clinic were included in thestudy. These patients were compared with those having lepidic,acinar, and mucinous subtypes. Overall and five-year survivalrates were evaluated.Results: Five-year survival was 40.5% in papillary predominanthistological subtype, while this rate was 70.9%, 59.0%, and66.6% in lepidic, acinar, and mucinous subtypes, respectively.Papillary subtype showed significantly poor survival comparedto lepidic (p=0.002), acinar (p=0.008), and mucinous subtypes(p=0.048). In Stage 1 disease, it was more evident (papillary,47.5%, lepidic 86.9% [p=0.001], acinar 69.3% [p=0.040], andmucinous 90.0% [p=0.050]).Conclusion: Our study results suggest that papillary predominantsubtype predicts poor survival in lung adenocarcinoma and thesecases may be candidates for adjuvant treatment modalities evenin the earlier stages of disease.
dc.identifier.DOI-ID10.5606/tgkdc.dergisi.2019.17284
dc.identifier.issn1301-5680
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/22468
dc.language.isoeng
dc.subject[Fen > Tıp > Kalp ve Kalp Damar Sistemi, Fen > Tıp > Cerrahi]
dc.titlePapillary predominant histological subtype predicts poor survival in lung adenocarcinoma
dc.typeAraştırma Makalesi

Files

Collections

TR-Dizin Koleksiyonu